Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy

The mucosal immune system, via a dynamic immune network, serves as the first line of defense against exogenous antigens. Mucosal immune system dysregulation is closely associated with the pathogenesis of immunoglobulin A nephropathy (IgAN), as illustrated by IgAN having the clinical feature of gross...

Full description

Bibliographic Details
Main Authors:	Toshiki Kano, Hitoshi Suzuki, Yuko Makita, Yoshihito Nihei, Yusuke Fukao, Maiko Nakayama, Mingfeng Lee, Rina Kato, Ryosuke Aoki, Koshi Yamada, Masahiro Muto, Yusuke Suzuki
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Biomedicines
Subjects:	IgA nephropathy gut-associated lymphoid tissue nasal-associated lymphoid tissue galactose-deficient IgA1
Online Access:	https://www.mdpi.com/2227-9059/10/12/3027

Similar Items

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
by: Yusuke Fukao, et al.
Published: (2022-06-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment
by: Yating Du, et al.
Published: (2023-01-01)

Characteristics of renal pathology and coagulation function in IgA nephropathy and IgA vasculitis associated nephritis
by: Yinhong Wang, et al.
Published: (2024-01-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Salivary IgA subtypes as novel disease biomarkers in systemic lupus erythematosus
by: Sandra Romero-Ramírez, et al.
Published: (2023-02-01)

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation
by: Herbert L. DuPont, et al.
Published: (2022-12-01)

Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy
by: Rakel Nurmi, et al.
Published: (2021-05-01)

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
by: Dita Maixnerova, et al.
Published: (2022-05-01)

Prevalence of tissue transglutaminase antibodies and IgA deficiency are not increased in juvenile idiopathic arthritis: a case-control study
by: Angela Taneja Kohli, et al.
Published: (2023-10-01)

Exercise improves intestinal IgA production by T-dependent cell pathway in adults but not in aged mice
by: Angel Joel Hernández-Urbán, et al.
Published: (2023-12-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy
by: Yun-Ting Juan, et al.
Published: (2022-07-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Intestinal Mucosa-Associated Lymphoid Tissue Lymphoma Transforming into Diffuse Large B-Cell Lymphoma in a Young Adult Patient with Neurofibromatosis Type 1: A Case Report
by: Hideki Kosako, et al.
Published: (2022-12-01)

The IgA of hares (Lepus sp.) and rabbit confirms that the leporids IgA explosion is old and reveals a new case of trans-species polymorphism
by: Ana Pinheiro, et al.
Published: (2023-08-01)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
by: Wencheng Xu, et al.
Published: (2023-06-01)

Characterization of IgA Deposition in the Kidney of Patients with IgA Nephropathy and Minimal Change Disease
by: Won-Hee Cho, et al.
Published: (2020-08-01)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023-08-01)

Elevated Total Serum Immunoglobulin A Levels in Patients with Suspicion for Celiac Disease
by: Twan Sia, et al.
Published: (2023-08-01)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
by: Maciej Tota, et al.
Published: (2023-04-01)

Successful treatment of refractory IgA vasculitis with tofacitinib
by: Yi-Fei Xu, MD, et al.
Published: (2022-12-01)

An Update on Current Therapeutic Options in IgA Nephropathy
by: Regina Shaoying Lim, et al.
Published: (2024-02-01)

Evaluation of the Usefulness of a Serological Test for Diagnosis of Celiac Disease Simultaneously Detecting Specific Antibodies and Total IgA
by: Emilia Majsiak, et al.
Published: (2022-12-01)

IgA Vasculitis Complicated by Both CMV Reactivation and Tuberculosis
by: Małgorzata Mizerska-Wasiak, et al.
Published: (2021-07-01)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
by: Jia-Wei He, et al.
Published: (2022-03-01)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system
by: C Wang, et al.
Published: (2011-12-01)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
by: Jia-Wei He, et al.
Published: (2023-06-01)

Persistent Hyper IgA as a Marker of Immune Deficiency: A Case Report
by: Russell J. Hopp, et al.
Published: (2022-04-01)

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression
by: Sigridur Elíasdóttir, et al.
Published: (2023-06-01)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01)

Secretory IgA impacts the microbiota density in the human nose
by: Rob van Dalen, et al.
Published: (2023-10-01)

The Usefulness of Vanin-1 and Periostin as Markers of an Active Autoimmune Process or Renal Fibrosis in Children with IgA Nephropathy and IgA Vasculitis with Nephritis—A Pilot Study
by: Małgorzata Mizerska-Wasiak, et al.
Published: (2022-02-01)

Linear IgA Bullous Dermatosis: A Case Report [Lineer IgA Bulloz Dermatozu: Olgu Sunumu]
by: Nihal Altunisik, et al.
Published: (2016-09-01)

Tryptophan Attenuates the Effects of OTA on Intestinal Morphology and Local IgA/IgY Production in Broiler Chicks
by: Fernando Galdino Ricci, et al.
Published: (2020-12-01)

Pathogenesis of IgA Nephropathy: Current Understanding and Implications for Development of Disease-Specific Treatment
by: Barbora Knoppova, et al.
Published: (2021-09-01)